Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Neumann

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
European Journal of Cancer Care|September 13, 2012
Quality-adjusted life years in cancer: pros, cons, and alternativesR M Woodward, J Menzin, P J Neumann
Health Affairs (Project Hope)|January 23, 1999
Alzheimer's disease care: costs and potential savingsJ Leon, C K Cheng, P J Neumann
The New England Journal of Medicine|July 28, 1994
The cost of a successful delivery with in vitro fertilizationP J Neumann, S D Gharib, M C Weinstein
Alzheimer Disease and Associated Disorders|August 28, 2001
The association between caregiver burden and caregiver health-related quality of life in Alzheimer diseaseC M Bell, S S Araki, P J Neumann
International Journal of Technology Assessment in Health Care|January 1, 1996
Potential savings from using information technology applications in health care in the United StatesP J Neumann, S T Parente, L C Paramore
Annual Review of Public Health|July 8, 2000
Preference-based measures in economic evaluation in health careP J Neumann, S J Goldie, M C Weinstein
Journal of the American Geriatrics Society|December 29, 2000
The use of proxy respondents in studies of older adults: lessons, challenges, and opportunitiesP J Neumann, S S Araki, E M Gutterman
Health Affairs (Project Hope)|January 1, 1996
The FDA and regulation of cost-effectiveness claimsP J Neumann, D E Zinner, A D Paltiel
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 31, 1997
Are methods for estimating QALYs in cost-effectiveness analyses improving?P J Neumann, D E Zinner, J C Wright
International Journal of Technology Assessment in Health Care|May 2, 2001
Bayesian value-of-information analysis. An application to a policy model of Alzheimer's diseaseK Claxton, P J Neumann, S Araki, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
European Journal of Cancer Care|September 13, 2012
Quality-adjusted life years in cancer: pros, cons, and alternativesR M Woodward, J Menzin, P J Neumann
Health Affairs (Project Hope)|January 23, 1999
Alzheimer's disease care: costs and potential savingsJ Leon, C K Cheng, P J Neumann
The New England Journal of Medicine|July 28, 1994
The cost of a successful delivery with in vitro fertilizationP J Neumann, S D Gharib, M C Weinstein
Alzheimer Disease and Associated Disorders|August 28, 2001
The association between caregiver burden and caregiver health-related quality of life in Alzheimer diseaseC M Bell, S S Araki, P J Neumann
International Journal of Technology Assessment in Health Care|January 1, 1996
Potential savings from using information technology applications in health care in the United StatesP J Neumann, S T Parente, L C Paramore
Annual Review of Public Health|July 8, 2000
Preference-based measures in economic evaluation in health careP J Neumann, S J Goldie, M C Weinstein
Journal of the American Geriatrics Society|December 29, 2000
The use of proxy respondents in studies of older adults: lessons, challenges, and opportunitiesP J Neumann, S S Araki, E M Gutterman
Health Affairs (Project Hope)|January 1, 1996
The FDA and regulation of cost-effectiveness claimsP J Neumann, D E Zinner, A D Paltiel
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 31, 1997
Are methods for estimating QALYs in cost-effectiveness analyses improving?P J Neumann, D E Zinner, J C Wright
International Journal of Technology Assessment in Health Care|May 2, 2001
Bayesian value-of-information analysis. An application to a policy model of Alzheimer's diseaseK Claxton, P J Neumann, S Araki, et al.
Pageof 6